Clinical Trials Directory

Trials / Conditions / Pancreatic Acinar Cell Carcinoma

Pancreatic Acinar Cell Carcinoma

9 registered clinical trials studyying Pancreatic Acinar Cell Carcinoma2 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingThe PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Assoc
NCT06115499
Alliance for Clinical Trials in OncologyPhase 2 / Phase 3
TerminatedOlaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
NCT05286827
National Cancer Institute (NCI)Phase 2
RecruitingAPOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy
NCT04858334
National Cancer Institute (NCI)Phase 2
RecruitingSHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04150042
General Oncology, Inc.Phase 1
Active Not RecruitingNivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
National Cancer Institute (NCI)Phase 2
CompletedSelumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Pa
NCT01658943
National Cancer Institute (NCI)Phase 2
CompletedCarboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pan
NCT01280058
National Cancer Institute (NCI)Phase 2
Active Not RecruitingVaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
NCT00669734
National Cancer Institute (NCI)Phase 1
Active Not RecruitingGDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metas
NCT00878163
National Cancer Institute (NCI)Phase 1